- Report
- August 2024
- 175 Pages
Global
From €4739EUR$5,000USD£3,959GBP
- Report
- February 2025
- 200 Pages
Global
From €4256EUR$4,490USD£3,555GBP
- Report
- August 2024
- 175 Pages
Global
From €4739EUR$5,000USD£3,959GBP
- Report
- February 2025
- 200 Pages
Global
From €4256EUR$4,490USD£3,555GBP
- Report
- May 2024
- 132 Pages
Global
From €6160EUR$6,499USD£5,146GBP
- Report
- July 2024
- 185 Pages
Global
From €4265EUR$4,500USD£3,563GBP
- Report
- December 2023
- 116 Pages
Global
From €4265EUR$4,500USD£3,563GBP
- Report
- January 2024
- 89 Pages
Global
From €3500EUR$3,956USD£3,026GBP
- Report
- March 2024
- 132 Pages
Global
From €900EUR$950USD£752GBP
Fecal softeners are a type of gastrointestinal drug used to treat constipation. They work by increasing the amount of water in the stool, making it easier to pass. Fecal softeners are typically taken orally, either as a liquid or a pill. They are often used in combination with other medications, such as laxatives, to treat constipation. Fecal softeners are generally considered safe and effective, but they can cause side effects such as abdominal cramps, nausea, and diarrhea.
The fecal softener market is a growing segment of the gastrointestinal drug market. It is driven by an aging population, increasing prevalence of chronic diseases, and rising awareness of the importance of digestive health. Fecal softeners are increasingly being prescribed as a first-line treatment for constipation, as they are considered to be safer and more effective than other treatments.
Some companies in the fecal softener market include GlaxoSmithKline, Pfizer, Merck, and Bayer. Show Less Read more